MA45852A - Bactéries lactiques et leur utilisation pour le traitement préventif, inhibiteur et/ou réducteur de la formation de biofilms bactériens - Google Patents

Bactéries lactiques et leur utilisation pour le traitement préventif, inhibiteur et/ou réducteur de la formation de biofilms bactériens

Info

Publication number
MA45852A
MA45852A MA045852A MA45852A MA45852A MA 45852 A MA45852 A MA 45852A MA 045852 A MA045852 A MA 045852A MA 45852 A MA45852 A MA 45852A MA 45852 A MA45852 A MA 45852A
Authority
MA
Morocco
Prior art keywords
preventive
inhibitor
formation
reducing treatment
lactic bacteria
Prior art date
Application number
MA045852A
Other languages
English (en)
Inventor
Giovanni Mogna
Original Assignee
Flame S R L
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flame S R L, Probiotical Spa filed Critical Flame S R L
Publication of MA45852A publication Critical patent/MA45852A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA045852A 2016-08-03 2017-08-02 Bactéries lactiques et leur utilisation pour le traitement préventif, inhibiteur et/ou réducteur de la formation de biofilms bactériens MA45852A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000081420A IT201600081420A1 (it) 2016-08-03 2016-08-03 Batteri lattici e loro uso per il trattamento preventivo, inibitorio,riduttivo della formazione del biofilm batterico

Publications (1)

Publication Number Publication Date
MA45852A true MA45852A (fr) 2019-06-12

Family

ID=57610281

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045852A MA45852A (fr) 2016-08-03 2017-08-02 Bactéries lactiques et leur utilisation pour le traitement préventif, inhibiteur et/ou réducteur de la formation de biofilms bactériens

Country Status (11)

Country Link
US (1) US20200199692A1 (fr)
EP (1) EP3494206B1 (fr)
JP (1) JP2019524159A (fr)
KR (1) KR20190103135A (fr)
CN (1) CN110191945A (fr)
BR (1) BR112019001984A2 (fr)
CA (1) CA3032335A1 (fr)
IT (1) IT201600081420A1 (fr)
MA (1) MA45852A (fr)
RU (1) RU2019105733A (fr)
WO (1) WO2018025204A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
WO2020234382A1 (fr) * 2019-05-20 2020-11-26 Lactobio Aps Composition pour le traitement, l'amélioration ou la prophylaxie de l'acné
CN110628663B (zh) * 2019-08-02 2021-12-17 华南理工大学 一株鼠李糖乳杆菌及其高密度培养方法和应用
CN112063548A (zh) * 2020-08-19 2020-12-11 杭州医学院 一株具有产蛋白酶能力的植物乳杆菌及其应用
CN113046258B (zh) * 2020-10-09 2023-04-28 江南大学 一株能够预防和/或治疗牙周炎的鼠李糖乳杆菌及其应用
US20220110918A1 (en) * 2020-10-09 2022-04-14 Script Essentials, Llc Compositions and methods for treatment of skin-related diseases and promoting dermatological health
WO2022236527A1 (fr) * 2021-05-10 2022-11-17 合肥工业大学 Procédé pour empêcher la formation d'un biofilm bactérien nuisible sur la surface d'un produit en acier inoxydable
CN113080461A (zh) * 2021-05-14 2021-07-09 艾兰得生物科技研究泰州有限公司 一种具有抑制奇异变形杆菌生长作用的益生菌及其发酵液和应用
CN113462616A (zh) * 2021-08-19 2021-10-01 上海昊岳食品科技有限公司 一株人源鼠李糖乳杆菌glr8及其制备方法
CN118516252A (zh) * 2024-04-18 2024-08-20 南京农业大学 一株乳酸菌菌株及其在制备促进皮肤伤口修复的胞外多糖敷料中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011007584A1 (fr) * 2009-07-16 2011-01-20 国立大学法人広島大学 Agent prophylactique, d'amélioration et thérapeutique pour maladies buccales
CA2831345C (fr) * 2011-05-06 2022-05-03 Organobalance Medical Ag Lignees bacteriennes d'acide lactique qui font coagregat avec staphylococcus aureus, et compositions et utilisations des lignees
FR2999601B1 (fr) * 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis

Also Published As

Publication number Publication date
WO2018025204A1 (fr) 2018-02-08
RU2019105733A (ru) 2020-09-04
EP3494206B1 (fr) 2021-07-07
EP3494206A1 (fr) 2019-06-12
US20200199692A1 (en) 2020-06-25
JP2019524159A (ja) 2019-09-05
IT201600081420A1 (it) 2018-02-03
BR112019001984A2 (pt) 2019-05-07
CA3032335A1 (fr) 2018-02-08
KR20190103135A (ko) 2019-09-04
CN110191945A (zh) 2019-08-30

Similar Documents

Publication Publication Date Title
MA45852A (fr) Bactéries lactiques et leur utilisation pour le traitement préventif, inhibiteur et/ou réducteur de la formation de biofilms bactériens
EP3390357A4 (fr) Composés de biarylmonobactame et procédés d'utilisation correspondants pour le traitement d'infections bactériennes
EP3426248A4 (fr) Composés d'arylmonobactame bicycliques et leurs méthodes d'utilisation pour le traitement des infections bactériennes
EP3645017A4 (fr) Compositions, procédés et utilisations pour le nettoyage, la désinfection et/ou la stérilisation
EP3370748A4 (fr) Microbiote thérapeutique pour le traitement et/ou la prévention de l'allergie alimentaire
MA41013B1 (fr) Compositions comprenant des souches bactériennes
MD3240554T2 (ro) Blautia stercosis și wexlerae pentru utilizare în tratarea bolilor inflamatorii și autoimune
IL271863B (en) Compounds and use thereof for the treatment of microbial infections
EP3374350A4 (fr) Composés à base d'hydroxypyridinone et d'hydroxypyrimidinone pour le traitement d'infections bactériennes
EP3294761A4 (fr) Compositions et méthodes de traitement et de prévention de l'infection pare. coli
EP3285776A4 (fr) Méthodes de traitement d'infections bactériennes
EP3737425A4 (fr) Compositions, kits, procédés et utilisations pour le nettoyage, la désinfection, la stérilisation et/ou le traitement
IL270976A (en) IL-8 inhibitors for use in the treatment and/or prevention of secondary bacterial infection
EP3579837C0 (fr) Axitinib, nintedanib ou lenvatinib pour le traitement de la rosacée et de la dermatite atopique
EP3801478A4 (fr) Méthodes et compositions pour la prévention ou le traitement de la calciphylaxie
DK3432900T3 (da) Mælkesyrebakteriesammensæting til behandling af bakterielle vaginale infektioner forårsaget af gardnerella vaginalis og, hvis de forefindes, samtidige svampeinfektioner
EP3468555C0 (fr) Compositions pour utilisation dans le traitement d'infections bactériennes
LT3630111T (lt) Junginiai ir būdai, skirti bakterinių infekcijų gydymui
SMT201900692T1 (it) Composizione per l'uso del trattamento delle infezioni batteriche
PT3565551T (pt) Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem
LT3554501T (lt) Deksmedetomidinas arba medetomidinas, skirti naudoti gydant naminių gyvūnų atsiskyrimo nerimą
PL3856213T3 (pl) Sposoby leczenia zakażenia z zastosowaniem bakterii
FR3022139B1 (fr) Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee
EP3533471A4 (fr) Composition pour le soulagement ou le traitement de la douleur
EP3634471A4 (fr) Composés de carbapenem et compositions pour le traitement d'infections bactériennes